Research graph

References

References from PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT). Local targets link to admitted publications; unresolved targets remain external evidence.

The Ras radiation resistance pathway

2001 · External reference

Targeting the phosphoinositide 3-kinase pathway in cancer

10.1038/nrd2926 · 2009 · External reference

Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC

10.1016/j.ctrv.2013.08.006 · 2014 · External reference

Mutation of the PIK3CA oncogene in human cancer

10.1038/sj.bjc.6602970 · 2006 · External reference

Phase I dose-escalation study of taselisib, an oral PI3K inhibitor, in patients with advanced solid tumors

10.1158/2159-8290.cd-16-1080 · 2017 · External reference

PIK3CA mutations as prognostic factor in squamous cell lung carcinoma

10.1016/j.lungcan.2016.11.018 · 2017 · External reference

PIK3CA mutation associates with improved outcome in breast cancer

10.1158/1078-0432.ccr-09-0632 · 2009 · External reference

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma

2013 · External reference

Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients

10.18632/oncotarget.15966 · 2017 · External reference